SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-198165
Filing Date
2019-07-19
Accepted
2019-07-19 17:15:35
Documents
2
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.BRASLYN LTD.CHRISTOPHER FUGLESANGIVAN M. LIEBERBURGJOE LEWISMVA INVESTORS, LLCSHEHAN B. DISSANAYAKE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d768953dsc13da.htm SC 13D/A 178427
2 EX-99.1 d768953dex991.htm EX-99.1 10613
  Complete submission text file 0001193125-19-198165.txt   190821
Mailing Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87670 | Film No.: 19964124
SIC: 2834 Pharmaceutical Preparations